Primary biliary cholangitis trials in United States

In United States 11 Also abroad 41

11 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Where
Atlanta, Baltimore, Bethesda, Birmingham, Boston, Charleston, Chicago, Cleveland, Columbus, Cordova, Dallas, Denison, Detroit, Fairfax, Fort Myers, Hershey, Iowa City, Jefferson, Lancaster, Los Angeles, Louisville, Manhasset, Miami, Milwaukee, New Orleans, Newport News, New York, Pasadena, Philadelphia, Phoenix, Pittsburgh, Portland, Redwood City, Richmond, Rochester, Roseville, Sacramento, San Antonio, San Francisco, Sarasota, Seattle, South San Francisco, Tampa, Winston-Salem
Age
18 years and over
People
402 worldwide
Run by
Gilead Sciences
See details and how to joinNCT06051617 · EU 2024-516525-31-01
No phaseTaking people
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Where
Sioux Falls
People
20,000
Run by
Sanford Health
See details and how to joinNCT01793168
Phase 2Taking people
Study of Seladelpar and Cilofexor in Participants With Primary Biliary Cholangitis
Where
Atlanta, Colorado Springs, Johnson City, Lakewood Rch
Age
18 years to 75 years
People
132
Run by
Gilead Sciences
See details and how to joinNCT07841977
Phase 3Taking people
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Where
Albuquerque, Ann Arbor, Arlington, Aurora, Austin, Charleston, Charlottesville, Colorado Springs, Columbia, Cordova, Coronado, Dallas, Englewood, Fort Worth, Houston, Huntington, Kansas City, Katy, Little Rock, Littleton, Los Angeles, Miami, New York, Pembroke Pines, Pittsburgh, Richmond, Rochester, Sacramento, San Antonio, Seattle, Shreveport, Tampa, Tucson, Waco, Ypsilanti
Age
18 years and over
People
276 worldwide
Run by
Ipsen
See details and how to joinNCT06016842 · EU 2023-505251-43-00
No phaseTaking people
Elafibranor Pregnancy Surveillance Program: A Study to Evaluate the Safety of Elafibranor During Pregnancy
Where
Wilmington
People
3
Run by
Ipsen
See details and how to joinNCT07556913
Phase 2Not yet taking people in United States
Nemolizumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus
Where
Jacksonville
Age
18 years and over
People
15
Run by
Mayo Clinic
See details and how to joinNCT07843420
Phase 3Taking people
Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy
Where
Lakewood Rch
Age
18 years to 80 years
People
90 worldwide
Run by
Zydus Therapeutics Inc.
See details and how to joinNCT07424677 · EU 2026-526680-38-00
Phase 1Taking people
Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
Where
Indianapolis
Age
18 years to 80 years
People
6
Run by
Zydus Therapeutics Inc.
See details and how to joinNCT06825559
Phase 3Taking people
Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes
Where
Houston, Indianapolis, Marietta
Age
18 years to 64 years
People
386 worldwide
Run by
Zydus Therapeutics Inc.
See details and how to joinNCT07216235 · EU 2025-524067-20-00
No phaseEnrolling by invitation
Using Digital Health Technology to Monitor Patients With Primary Biliary Cholangitis (PBC)
Where
Redwood City
Age
18 years and over
People
30
Run by
Stanford University
See details and how to joinNCT07631442
No phaseTaking people
Biobank for Cholestatic Liver Diseases.
Where
Rochester
Age
18 years to 85 years
People
9,150
Run by
Mayo Clinic
See details and how to joinNCT03445585